about
Assessment of morbidity in gynaecologic oncology laparoscopy and identification of possible risk factorsInsulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study.Method to calculate the protamine dose necessary for reversal of heparin as a function of activated clotting time in patients undergoing cardiac surgeryThe role of the adenomatous polyposis coli (APC) in oral squamous cell carcinoma.Tissue inhibitor of metalloproteinases in oral squamous cell carcinomas - a therapeutic target?Impact of subject's position and acoustic stimulus type on vestibular evoked myogenic potentials (VEMPs) in normal subjects.Expression of CA IX in dysplasia adjacent to surgical resection margins of oral squamous cell carcinoma.Can we predict the risk of falls in elderly patients with instability?Short-term effectiveness of vestibular rehabilitation in elderly patients with postural instability: a randomized clinical trial.Adherence of older people with instability in vestibular rehabilitation programmes: prediction criteria.Impact of obesity in elderly patients with postural instability.Balance Disorders in the Elderly: Does Instability Increase Over Time?Is there a relationship between short FES-I test scores and objective assessment of balance in the older people with age-induced instability?Risk factors associated with Helicobacter pylori infection. A population-based study conducted in the province of Ourense.The use of CA-IX as a diagnostic method for oral leukoplakia.Insulin resistance index (HOMA-IR) levels in a general adult population: curves percentile by gender and age. The EPIRCE study.Factors affecting peri-implant bone loss: a post-five-year retrospective study.Strategy to estimate risk progression of chronic kidney disease, cardiovascular risk, and referral to nephrology: the EPIRCE Study.[Prediction of mortality and quality of life in polytraumatized patients: APACHE II versus APACHE III][Auricular fibrillation as a risk factor of cerebrovascular events in the over-65s. Is clinical practice in anticoagulant prophylaxis adequate?].[Re-classification of kidney function in 65-75 year-old males according to the MDRD and CKD-EPI calculated glomerular filtration rate].Disability perception in Menière's disease: when, how much and why?Reduction of falls in older people by improving balance with vestibular rehabilitation (ReFOVeRe study): design and methods.Quantitative determination of c-myc facilitates the assessment of prognosis of OSCC patients.Activity of β2-adrenergic receptor in oral squamous cell carcinoma is mediated by overexpression of the ADRBK2 gene: a pilot study.The Loss of p16 Expression Worsens the Prognosis of OSCC.Is there a relationship between objective and subjective assessment of balance in elderly patients with instability?[Family medicine tutors: attitudes and activities of tutoring][The evaluation of apparatus for measuring capillary cholesterol][Assessment of drug treatment for hypertension in a health centre as a function of associated chronic pathologies and degree of control of the hypertension][Delegated accreditation or delayed accreditation?]Incidence and characteristics of myelodysplastic syndromes in Ourense (Spain) between 1994-1998Prevalence of Helicobacter pylori infection in the general adult population of the province of Ourense[The tuberculin skin test in a healthy child program: should we change our practice][Study of the prevalence of urinary incontinence in women from 18 to 65 and its influence on their quality of life][Polipharmacy in the antipsychotic prescribing in practices psychiatric out-patient clinic]Non-computer-assisted liquid-based cytology for diagnosis of oral squamous cell carcinomaEvaluating the Performance of the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines (CRUSADE) bleeding score in a contemporary Spanish cohort of patients with non-BCL10 expression is unrelated to clinico-pathological parameters or prognoses for oral squamous cell carcinomas
P50
Q26771627-954ECF36-ED1A-43B1-ADF1-FDDE9DE831C7Q33592719-93D02868-AC66-4A55-8817-B6E16763D931Q36019219-2358E261-D2E6-4E6F-818B-6370806C3B4AQ37936654-379C3817-42C8-4246-928E-76397119BB6FQ38000930-4A86434A-A49E-402C-AD8C-31AD452652F7Q38225454-B2446DAF-AA92-4CF6-9CDB-430D8265B5C9Q38395239-50CD09C6-01D3-444F-A939-4354A37BA054Q39133683-D536443F-36C0-4625-9DE6-22EE8B7055DEQ40312081-3C27F575-BD70-4D91-A453-005E00195BCFQ40380494-5A1F41B3-8FFF-4928-B8EE-7E218820E72BQ40723775-A4984E49-DC72-4268-9BFA-7A758AF9CC9DQ40928252-D0348608-927C-492A-BF81-9B046F397087Q41301014-6CFF6E46-5192-403C-95C3-E5EA9A7F8CE3Q42597039-6A6978F7-C1F3-427E-89E9-C9D7F38A0278Q43324335-F1A8A4FA-4F30-4E67-B626-2FC6B127660BQ43722388-634885BC-62AF-4F06-BC0E-D0D4595BA8CBQ43904463-0BF670C8-9C72-4B33-9D77-83CA65F585F0Q44265318-C32681E8-28B9-45A5-BA6D-0AB989412615Q45199302-25CB1807-FDB4-4923-87CE-A203CA74A3DDQ46695102-1BC40221-146B-4B28-B4FD-7BFC79005D90Q50213489-8D58A1F9-429A-46C1-B348-027B8A64DB78Q50352639-3D896D50-2369-4444-B53D-F8281AE05111Q50560259-E4A6DF58-1887-42D1-A0D8-2A74AD976D6CQ53064737-25659165-F4DC-4BD6-B439-E29979D72D5CQ53281714-B7E305D2-8847-4572-972B-2E34532D2E98Q54295319-524B4180-E07C-45CA-BA10-6006531B910FQ58751697-D55A31E5-3C3C-472A-AC62-4184BE36DDB8Q72327427-B661BE06-B168-4761-B6EE-95013CDB811CQ73712498-951B04D8-1DB3-45C5-875E-BF2BE9C7CA1CQ74291298-D508544F-8348-4526-BCB7-23E3223F5E70Q77577860-D611FA32-9398-4A77-B821-BE6D1DEC6BCAQ79157165-9F8EF937-5058-403F-9D98-627FE710F0E6Q79771066-7AC380AF-851A-4B61-A7AE-F314423D4281Q80221504-57BE2149-0AB7-4AFA-90AC-F430168D274EQ80380770-5263E4BB-E142-4F43-8AA4-9C8374583479Q80969545-D0918A0B-CA52-4161-93B4-7B7701C90506Q83990345-817DFEE6-8B5E-4069-829A-AC01488CEA2FQ84290928-54414905-0E2D-4E1D-AA77-EDD44FDAE804Q84461448-C97C9228-3E72-4179-9418-2A854B106153
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pilar Gayoso-Diz
@ast
Pilar Gayoso-Diz
@de
Pilar Gayoso-Diz
@en
Pilar Gayoso-Diz
@es
Pilar Gayoso-Diz
@fr
Pilar Gayoso-Diz
@it
Pilar Gayoso-Diz
@nl
type
label
Pilar Gayoso-Diz
@ast
Pilar Gayoso-Diz
@de
Pilar Gayoso-Diz
@en
Pilar Gayoso-Diz
@es
Pilar Gayoso-Diz
@fr
Pilar Gayoso-Diz
@it
Pilar Gayoso-Diz
@nl
prefLabel
Pilar Gayoso-Diz
@ast
Pilar Gayoso-Diz
@de
Pilar Gayoso-Diz
@en
Pilar Gayoso-Diz
@es
Pilar Gayoso-Diz
@fr
Pilar Gayoso-Diz
@it
Pilar Gayoso-Diz
@nl
P106
P21
P31
P496
0000-0002-5872-0057